C4 Therapeutics, Inc. Forecasted to Post Q3 2021 Earnings of ($0.74) Per Share (NASDAQ:CCCC)

Retrieved on: 2021-08-16 06:03:18

Tags for this article:

Click the tags to see associated articles and topics

C4 Therapeutics, Inc. Forecasted to Post Q3 2021 Earnings of ($0.74) Per Share (NASDAQ:CCCC). View article details on hiswai:

Excerpt

BlackRock Inc. now owns 2,632,424 shares of the company's stock worth $99,610,000 after buying an additional 1,437,932 shares during the period.

Article found on: www.marketbeat.com